- Home
- BDRX vs UPC Comparison
BDRX vs UPC Comparison
Compare BDRX & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- UPC
- Stock Information
- Founded
- BDRX 2000
- UPC 1998
- Country
- BDRX United Kingdom
- UPC China
- Employees
- BDRX N/A
- UPC N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- UPC Biotechnology: Pharmaceutical Preparations
- Sector
- BDRX Health Care
- UPC Health Care
- Exchange
- BDRX Nasdaq
- UPC Nasdaq
- Market Cap
- BDRX 2.8M
- UPC 6.2M
- IPO Year
- BDRX N/A
- UPC 2021
- Fundamental
- Price
- BDRX $5.98
- UPC $0.40
- Analyst Decision
- BDRX Strong Buy
- UPC
- Analyst Count
- BDRX 1
- UPC 0
- Target Price
- BDRX $200.00
- UPC N/A
- AVG Volume (30 Days)
- BDRX 455.7K
- UPC 4.3M
- Earning Date
- BDRX 10-29-2024
- UPC 01-01-0001
- Dividend Yield
- BDRX N/A
- UPC N/A
- EPS Growth
- BDRX N/A
- UPC N/A
- EPS
- BDRX N/A
- UPC N/A
- Revenue
- BDRX $104,895.00
- UPC $26,725,919.00
- Revenue This Year
- BDRX N/A
- UPC N/A
- Revenue Next Year
- BDRX N/A
- UPC N/A
- P/E Ratio
- BDRX N/A
- UPC N/A
- Revenue Growth
- BDRX N/A
- UPC N/A
- 52 Week Low
- BDRX $4.71
- UPC $0.20
- 52 Week High
- BDRX $220.25
- UPC $4.32
- Technical
- Relative Strength Index (RSI)
- BDRX 42.77
- UPC 32.22
- Support Level
- BDRX $5.50
- UPC $0.31
- Resistance Level
- BDRX $10.89
- UPC $1.00
- Average True Range (ATR)
- BDRX 1.13
- UPC 0.09
- MACD
- BDRX 0.31
- UPC 0.13
- Stochastic Oscillator
- BDRX 20.55
- UPC 25.82
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
About UPC Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.